November 26, 2019
The recently released 20% subcutaneous immunoglobulin therapy expands treatment options offered by Advanced Infusion Care.
Valdosta, GA—Advanced Infusion Care, a division of AIS Healthcare, now offers Xembify®, developed by Grifols for the treatment of primary immune deficiency disease (PIDD).
AIC’s nationally accredited home infusion teams collaborate closely with physicians to provide specialized in-home infusion services. This new therapy option, offered under a limited distribution partnership with Grifols, expands AIC’s ability to serve
immunoglobulin (Ig) infusion patients.
“We’re proud to be able to add Xembify® to our growing list of Ig infusion therapies,” said Jud Hall, Senior Vice President at AIS Healthcare. “This new therapy from Grifols can help us provide additional treatment options for our PIDD patients.”
Xembify® is for the treatment of PIDD in patients 2 years of age and older. Approved by the U.S. Food and Drug Administration on July 3, 2019, the therapy was launched in the United States on November 18 and is now available at all AIC locations.
Like all AIC patients, PIDD patients receive a high level of care from AIC, including 24/7 access to clinical and support staff. Every patient is assigned a dedicated team of professionals, including clinical pharmacists, infusion nurse specialists, patient care
managers and intake managers, to provide support throughout the treatment process.
For physicians, AIC is a full-service care delivery partner. We have contracts with multiple immunoglobulin suppliers like Grifols to help ensure prescribed therapies are always in stock. We also work directly with patients, insurance companies and physician offices to secure all needed authorizations and complete paperwork.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC).
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at aiscaregroup.com/advanced-infusioncare-overview.php.
Advancing quality. Improving lives.
As the nation’s top intrathecal and infusion care solutions provider, AIS Healthcare is committed to doing more of what matters for patients and providers. From the industry leading quality and sterility standards at our pharmacies to our comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do. Because when we do more to advance care quality, providers are empowered and patients are supported. Days get easier. Lives get better.
Learn more at aiscaregroup.com
Grifols is a global healthcare company with more than 75 years of history improving the health and well-being of people around the world. Grifols produces essential plasma medicines for patients and provides hospitals, pharmacies and healthcare professionals with the tools, information and services they need to efficiently deliver expert medical care. Grifols’ three divisions—Bioscience, Diagnostic and Hospital—develop, produce and market innovative products and services available in more than 100 countries.
Learn more at grifols.com